Plain-English translation of NCT07143045 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether a new medication called works better than other standard lung cancer treatments for patients with advanced lung cancer that has spread to the brain or spinal cord lining. Researchers want to understand how well this medication helps patients live longer and what side effects it causes. You would be assigned to receive either the new medication or one of the standard treatments doctors typically use.
Brain tumors from lung cancer are very difficult to treat because standard medications often don't reach the brain well enough. This trial exists to see whether this new treatment can cross into the brain more effectively and help patients with this serious condition live longer.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic regularly for doctor visits, imaging scans (like MRIs), and blood tests to see how you are responding to treatment and check for side effects. Depending on which group you are assigned to, you would either take the new medication or receive one of the standard treatments your doctor chooses. The study will track how long you live, how well the cancer responds, and any side effects you experience over time.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China